{"id":"https://openalex.org/W4361891779","doi":"https://doi.org/10.1158/1078-0432.22487567","title":"Supplementary Data from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors \u2013 Efficacy, Safety, and Biomarker Results","display_name":"Supplementary Data from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors \u2013 Efficacy, Safety, and Biomarker Results","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361891779","doi":"https://doi.org/10.1158/1078-0432.22487567"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22487567","doi":"https://doi.org/10.1158/1078-0432.22487567","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487567","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22487567","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079753000","display_name":"Geoffrey John Lindeman","orcid":"https://orcid.org/0000-0001-9386-2416","observed_orcids":["https://orcid.org/0000-0001-9386-2416"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey J. Lindeman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9386-2416","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071050912","display_name":"Tharu M. Fernando","orcid":"https://orcid.org/0000-0001-9672-6428","observed_orcids":["https://orcid.org/0000-0001-9672-6428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tharu M. Fernando","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9672-6428","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055277830","display_name":"Rebecca L. Bowen","orcid":"https://orcid.org/0000-0002-1169-6125","observed_orcids":["https://orcid.org/0000-0002-1169-6125"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Bowen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057024351","display_name":"Katarzyna Joanna Jerzak","orcid":"https://orcid.org/0000-0002-3995-0308","observed_orcids":["https://orcid.org/0000-0002-3995-0308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katarzyna J. Jerzak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109357329","display_name":"Xinni Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinni Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029656956","display_name":"Thomas W. Decker","orcid":"https://orcid.org/0000-0003-3814-8775","observed_orcids":["https://orcid.org/0000-0003-3814-8775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Decker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3814-8775","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072172554","display_name":"Frances M. Boyle","orcid":"https://orcid.org/0000-0003-3798-1570","observed_orcids":["https://orcid.org/0000-0003-3798-1570","https://orcid.org/0000-0003-1665-2137"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frances Boyle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002544057","display_name":"Steve McCune","orcid":"https://orcid.org/0000-0002-2207-9341","observed_orcids":["https://orcid.org/0000-0002-2207-9341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve McCune","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2207-9341","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056491116","display_name":"Anne Caroline Armstrong","orcid":"https://orcid.org/0000-0002-0774-7006","observed_orcids":["https://orcid.org/0000-0002-0774-7006"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Armstrong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0774-7006","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029807906","display_name":"Catherine Shannon","orcid":"https://orcid.org/0000-0002-2078-2869","observed_orcids":["https://orcid.org/0000-0002-2078-2869"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Shannon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2078-2869","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027212039","display_name":"Gianfilippo Bertelli","orcid":"https://orcid.org/0000-0002-1798-0098","observed_orcids":["https://orcid.org/0000-0002-1798-0098"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gianfilippo Bertelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071439910","display_name":"Ching\u2010Wei Chang","orcid":"https://orcid.org/0000-0001-9239-4403","observed_orcids":["https://orcid.org/0000-0001-9239-4403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ching-Wei Chang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9239-4403","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110346344","display_name":"Rupal M. Desai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rupal Desai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101659131","display_name":"Kushagra Gupta","orcid":"https://orcid.org/0000-0002-7155-1446","observed_orcids":["https://orcid.org/0000-0002-7155-1446"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kushagra Gupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046660353","display_name":"Timothy Richard Wilson","orcid":"https://orcid.org/0000-0003-0530-4663","observed_orcids":["https://orcid.org/0000-0003-0530-4663","https://orcid.org/0009-0009-5421-1755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy R. Wilson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017615220","display_name":"Aulde Fl\u00e9chais","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aulde Flechais","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9879999756813049},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6449999809265137},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.5320000052452087},{"id":"https://openalex.org/keywords/bcl-2-inhibition","display_name":"BCL-2 inhibition","score":0.5989999771118164},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5040000081062317},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.7799195051193237},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.7579233646392822},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6597404479980469},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6117501258850098},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6061829328536987},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6045535206794739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4869176149368286},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43404027819633484},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4297701120376587},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3479195833206177},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.20692706108093262},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1606578528881073},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.11942863464355469},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22487567","doi":"https://doi.org/10.1158/1078-0432.22487567","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487567","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22487567","doi":"https://doi.org/10.1158/1078-0432.22487567","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487567","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361948128","https://openalex.org/W4280651407","https://openalex.org/W3195429482","https://openalex.org/W2946914634","https://openalex.org/W3172867079","https://openalex.org/W2154868021","https://openalex.org/W2795131456","https://openalex.org/W7129212645","https://openalex.org/W2591424708","https://openalex.org/W3139283056"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"VERONICA:":[3],"Randomized":[4],"Phase":[5],"II":[6],"Study":[7],"of":[8],"Fulvestrant":[9],"and":[10,22],"Venetoclax":[11],"in":[12],"ER-Positive":[13],"Metastatic":[14],"Breast":[15],"Cancer":[16],"Post-CDK4/6":[17],"Inhibitors":[18],"\u2013":[19],"Efficacy,":[20],"Safety,":[21],"Biomarker":[23],"Results":[24]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-05T00:00:00"}